Harpoon Therapeutics Appoints Haibo Wang as Senior Vice President of Business Development
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced the appointment of Haibo Wang as Senior Vice President of Business Development.
- SOUTH SAN FRANCISCO, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced the appointment of Haibo Wang as Senior Vice President of Business Development.
- Mr. Wang brings 15 years of biopharma business development, finance, and mergers and acquisitions (M&A) transaction experience to Harpoon.
- "We are pleased to welcome Haibo as Senior Vice President of Business Development at Harpoon,” said Julie Eastland, President and CEO of Harpoon Therapeutics.
- Mr. Wang most recently served as Vice President of Business Development at Hummingbird Bioscience where he was responsible for the company’s end-to-end business development activities.